Chengdu NewRT Medical Technology

Private

ChengduHealthcare & Life Scienceshttps://nrtmedtech.com/

Last Round

Series E

Apr 3, 2026

Est. Valuation

$110M

Total Funding Raised

$313.17M

Company Overview

Chengdu NewRT Medical Technology is a biotechnology company that develops and produces medical isotopes and radiopharmaceuticals for the diagnosis and treatment of cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

radiopharmaceuticalsradioligand therapyRLTmedical isotopestheranosticsisotope productionFAP targeted therapynuclear medicinetargeted radionuclide therapycancer therapyGallium-68 generatorCDMO servicescontract development and manufacturing organizationinterventional oncologyLutetium-177Yttrium-90 microsphereActinium-225

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Chengdu NewRT Medical Technology Comps

Public and private peers based on sector, stage, and business model.

Chengdu NewRT Medical Technology comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Chengdu NewRT Medical Technology Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series E	Apr 3, 2026
Series D	Oct 10, 2025
Series C	Mar 14, 2024
Series B	Jul 16, 2019

View all Funding Rounds

Chengdu NewRT Medical Technology Investors

Notable investors and investment history

Chengdu NewRT Medical Technology investors
Investor	Rounds
HighLight Capital	Series E
Chengdu Aerotropolis Innovation & Venture Capital	Series D
PICC Capital Insurance Asset Management	Series D
Xingkong Capital	Series C
Hunan Provincial Caixin Industrial Fund Management	Series D
Efung Capital	Series E
Shenzhen Capital Group	Series D

View all Investors

Chengdu NewRT Medical Technology Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Chengdu NewRT Medical Technology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Chengdu NewRT Medical Technology's valuation, stock price, and market status.

Firmographic Details

HeadquartersChengdu

Employee Range9

Year Founded2016

Last FundingApr 3, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.